Table 1 Clinical characteristics of subjects
Characteristic | HFpEF (n = 9) | Control (n = 7) | p value <0.05 |
|---|---|---|---|
Age, years | 75 ± 10 | 62 ± 13 | 0.03 |
Women (%) | 75 | 71 | n.s. |
Body mass index | 33 ± 9 | 33 ± 10 | n.s. |
Hypertensive (%) | 67 | 75 | n.s. |
Hyperlipidemia (%) | 67 | 63 | n.s. |
Diabetes (%) | 56 | 25 | n.s. |
Coronary artery disease (%) | 56 | 29 | n.s. |
h/o CVA/TIA (%) | 50 | 0 | 0.02 |
h/o Afib (%) | 78 | 0 | <0.001 |
Smoking history (%) | 100 | 29 | <0.001 |
Current smoker (%) | 11 | 14 | n.s. |
Former smoker (%) | 89 | 14 | n.s. |
Medications | |||
ACEI/ARB (%) | 50 | 57 | n.s |
Beta-blocker (%) | 100 | 50 | 0.009 |
Aldosterone antagonist (%) | 0 | 0 | n.s. |
Statin (%) | 75 | 57 | n.s. |
Diuretic (%) | 44 | 43 | n.s. |